Güncel Seçilmiş Literatür

[1] Brandsma R, van Egmond ME, Tijssen MAJ, et al. Diagnostic approach to paediatric movement disorders: a clinical practice guide. Dev Med Child Neurol. 2021;63:252-258.

[2] Szejko N, Robinson S, Hartmann A, et al. European clinical guidelines for Tourette syndrome and other tic disorders-version 2.0. Part I: assessment. Eur Child Adolesc Psychiatry. 2022;31:383-402.

[3] Pringsheim T, Okun MS, Müller-Vahl K, et al. Practice guideline recommendations summary: Treatment of tics in people with Tourette syndrome and chronic tic disorders. Neurology. 2019;92:896-906; AAN patient/family summary endorsed by CNS/EAN.

[4] Andrén P, Roessner V, Szejko N, et al. European clinical guidelines for Tourette syndrome and other tic disorders-version 2.0. Part II: psychological interventions. Eur Child Adolesc Psychiatry. 2022;31:403-423.

[5] Roessner V, Eichele H, Stern JS, et al. European clinical guidelines for Tourette syndrome and other tic disorders-version 2.0. Part III: pharmacological treatment. Eur Child Adolesc Psychiatry. 2022;31:425-441.

[6] Pringsheim T, Ganos C, McGuire JF, et al. European Society for the Study of Tourette Syndrome 2022 criteria for clinical diagnosis of functional tic-like behaviours. Eur J Neurol. 2023;30:902-910.

[7] Gorodetsky C, Fasano A. Approach to the treatment of pediatric dystonia. Dystonia. 2022;1:10287.

[8] Vogt LM, Yang K, Tse G, et al. Recommendations for the management of initial and refractory pediatric status dystonicus. Mov Disord. 2024;39:1435-1445.

[9] AACPDM Care Pathway. Cerebral palsy and dystonia. American Academy for Cerebral Palsy and Developmental Medicine.

[10] Thomas T, Eyre M, Ferrarin E, et al. Evaluation, diagnosis, and treatment of Sydenham chorea: consensus guidelines. Pediatrics. 2025;156(6):e2025072466.

[11] EASL-ERN Clinical Practice Guidelines on Wilson's disease. Journal of Hepatology / EASL update 2025; AASLD Wilson disease practice guidance 2022.

[12] Diagnosis and treatment recommendations for glucose transporter 1 deficiency syndrome. Current consensus/recommendation literature, 2024/2025.

[13] Vogt L, Quiroz V, Ebrahimi-Fakhari D. Emerging therapies for childhood-onset movement disorders. Curr Opin Pediatr. 2024.

[14] MDS-PAS Pediatric Movement Disorders Course, 2025: genomics, gene therapy, neuromodulation, status dystonicus and transition care learning objectives.

[15] CHOP / Boston Children's / tertiary pediatric movement disorder resources for multidisciplinary clinical organization and follow-up models.

Kaynak Bağlantıları

https://lup.lub.lu.se/search/publication/a6cdc444-e5cb-4e91-a073-c82fee25a3fb

• https://link.springer.com/article/10.1007/s00787-021-01842-2
• https://link.springer.com/article/10.1007/s00787-021-01845-z
• https://link.springer.com/article/10.1007/s00787-021-01899-z
• https://www.aan.com/Guidelines/home/GetGuidelineContent/961

https://www.frontierspartnerships.org/journals/dystonia/articles/10.3389/dyst.2022.10287/full

https://www.aacpdm.org/publications/care-pathways/dystonia-in-cerebral-palsy

https://www.def-lab.org/wp-content/uploads/2024/04/2024-Vogt-Mov-Dis.pdf

https://easl.eu/news/easl-cpgs-wilsons-disease/

https://www.aasld.org/practice-guidelines/diagnosis-and-treatment-wilson-disease

https://education.movementdisorders.org/Detail/909/MDS-PAS-Pediatric-Movement-Disorders-Conference